Cover Image

MSC-derived exosomes attenuate hepatic fibrosis in primary sclerosing cholangitis through inhibition of Th17 differentiation

Primary sclerosing cholangitis (PSC) is an autoimmune cholangiopathy characterized by chronic inflammation of the biliary epithelium and periductal fibrosis, with no curative treatment available, and liver transplantation is inevitable for end-stage patients. Human placental mesenchymal stem cell (h...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wenyi Chen (Author), Feiyan Lin (Author), Xudong Feng (Author), Qigu Yao (Author), Yingduo Yu (Author), Feiqiong Gao (Author), Jiahang Zhou (Author), Qiaoling Pan (Author), Jian Wu (Author), Jinfeng Yang (Author), Jiong Yu (Author), Hongcui Cao (Author), Lanjuan Li (Author)
Format:	Book
Published:	Elsevier, 2024-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PREGNANCY WITH PRIMARY SCLEROSING CHOLANGITIS
by: E. A. Alexandrova, et al.
Published: (2016)

Role of Endoscopy in Primary Sclerosing Cholangitis
by: Purnima Bhat, et al.
Published: (2021)

Corrigendum to "A novel HIF2A mutation causes dyslipidemia and promotes hepatic lipid accumulation" [Pharmacol. Res. 194 (2023) 106851]
by: Feiqiong Gao, et al.
Published: (2024)

A novel HIF2A mutation causes dyslipidemia and promotes hepatic lipid accumulation
by: Feiqiong Gao, et al.
Published: (2023)

Linear scleroderma and primary sclerosing cholangitis: An undescribed association
by: Iñigo Navarro Fernández, et al.
Published: (2020)

Primary sclerosing cholangitis - an insidious enemy of the liver - case report
by: Kinga Knop, et al.
Published: (2022)

Characteristics of Intestinal Microecology during Mesenchymal Stem Cell-Based Therapy for Mouse Acute Liver Injury
by: Xiaotian Dong, et al.
Published: (2019)

Novel CLDN1 Deletion Associated with Ichthyosis, Sclerosing Cholangitis and Acquired Alopecia
by: Maleha S. Alsafri, et al.
Published: (2020)

The Potentiality of Herbal Remedies in Primary Sclerosing Cholangitis: From In Vitro to Clinical Studies
by: Elisa Ceccherini, et al.
Published: (2020)

Autoimmune hepatitis and primary sclerosing cholangitis overlap syndrome in inflammatory bowel diseases
by: Joanna Saganek, et al.
Published: (2023)

Primary sclerosing cholangitis associated with severe ulcerative colitis in a young man
by: José Cândido Caldeira Xavier Júnior, et al.
Published: (2013)

Impact of clinical manifestations and outcome of ulcerative colitis with primary sclerosing cholangitis in children
by: Chuen-Bin Jiang
Published: (2021)

Clinically oriented look into diagnostics and therapy of primary sclerosing cholangitis. Review of literature
by: Tymoteusz Ślósarz, et al.
Published: (2024)

The characteristics of pediatric ulcerative colitis with primary sclerosing cholangitis: A single-center study in Taiwan
by: Mu-Ming Chien, et al.
Published: (2021)

Fenofibrate in primary sclerosing cholangitis; a randomized, double‐blind, placebo‐controlled trial
by: Behzad Hatami, et al.
Published: (2022)

Characteristics and outcome of primary sclerosing cholangitis associated with inflammatory bowel disease in Asian children
by: Way Seah Lee, et al.
Published: (2019)

Impact of Total Epinephrine Dose on Long Term Neurological Outcome for Cardiac Arrest Patients: A Cohort Study
by: Xiaowei Shi, et al.
Published: (2021)

Liver transplantation in a child with sclerosing cholangitis due to Langerhans cell histiocytosis: a case report
by: Xue-Lian Wang, et al.
Published: (2024)

Dual Role of MSC-Derived Exosomes in Tumor Development
by: Rou Zhao, et al.
Published: (2020)

Evaluation of the effects of additional therapy with Berberis vulgaris oxymel in patients with refractory primary sclerosing cholangitis and primary biliary cholangitis: A quasi-experimental study
by: Zahra Naghibi, et al.
Published: (2021)

The Covert Surge: Murine Bile Acid Levels Are Associated With Pruritus in Pediatric Autoimmune Sclerosing Cholangitis
by: Katharina Meinel, et al.
Published: (2022)

Network proximity analysis as a theoretical model for identifying potential novel therapies in primary sclerosing cholangitis
by: Jessica Leighton, et al.
Published: (2024)

Clinical Features, Differential Diagnosis and Treatment of IgG<sub>4</sub>-Related Sclerosing Cholangitis
by: A. K. Guseva, et al.
Published: (2024)

IgG4-Related Sclerosing Cholangitis Involving the Intrahepatic Bile Ducts Diagnosed with Liver Biopsy
by: Malene Theilmann Thinesen, et al.
Published: (2018)

Etiology, Epidemiology, and Therapeutic Approaches for Primary Sclerosing Cholangitis in the Context of Concurrent Non-specific Inflammatory Bowel Diseases
by: Anna Olszewska, et al.
Published: (2024)

Neonatal sclerosing cholangitis with novel mutations in DCDC2 (doublecortin domain-containing protein 2) in Chinese children
by: Xia Wei, et al.
Published: (2023)

Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients
by: Gaj Pawel, et al.
Published: (2008)

Stent versus Balloon Dilation for the Treatment of Dominant Strictures in Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis
by: Marina Tucci Gammaro Baldavira Ferreira, et al.
Published: (2021)

The Impact of GFP Reporter Gene Transduction and Expression on Metabolomics of Placental Mesenchymal Stem Cells Determined by UHPLC-Q/TOF-MS
by: Jinfeng Yang, et al.
Published: (2017)

A unique case of IgG4-related skin disease and sclerosing cholangitis in a patient with previous hepatitis exposure
by: Gabrielle Brody, BS, et al.
Published: (2021)

Combining MSC Exosomes and Cerium Oxide Nanocrystals for Enhanced Dry Eye Syndrome Therapy
by: Ying Tian, et al.
Published: (2023)

MSC-Derived Exosome Promotes M2 Polarization and Enhances Cutaneous Wound Healing
by: Xiaoning He, et al.
Published: (2019)

Small duct autoimmune sclerosing cholangitis and Crohn colitis in a 10-year-old child. A case report and review of the literature
by: Larsen Erling, et al.
Published: (2012)

Quality of life (QoL) for people with primary sclerosing cholangitis (PSC): a pragmatic strategy for identifying relevant QoL issues for rare disease
by: Elena Marcus, et al.
Published: (2022)

Successful treatment of infliximab-induced psoriasiform skin lesions despite biologic therapy intensification in a paediatric patient with Crohn's disease and primary sclerosing cholangitis
by: Agata Wasilewska, et al.
Published: (2021)

Therapeutic Effect and Location of GFP-Labeled Placental Mesenchymal Stem Cells on Hepatic Fibrosis in Rats
by: Jiong Yu, et al.
Published: (2017)

Newly Diagnosed Colonic Adenocarcinoma: The Presenting Sign in a Young Woman with Undiagnosed Crohn's Disease in the Absence of Primary Sclerosing Cholangitis and a Normal Microsatellite Instability Profile
by: Brett Matthew Lowenthal, et al.
Published: (2017)

Pediatric Xanthogranulomatus cholangitis
by: Reda A. Zbaida, et al.
Published: (2018)

Recent Developed Strategies for Enhancing Chondrogenic Differentiation of MSC: Impact on MSC-Based Therapy for Cartilage Regeneration
by: Kangkang Zha, et al.
Published: (2021)

Past, current, and future trends in the prevalence of primary sclerosing cholangitis and inflammatory bowel disease across England (2015-2027): a nationwide, population-based studyResearch in context
by: Hannah Crothers, et al.
Published: (2024)